MetLife Investment Management
ARDT icon

MetLife Investment Management’s Ardent Health ARDT Stock Holding History

MetLife Investment Management’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Sell
13,605
-425
-3% -$4.03K ﹤0.01% 2635
2026
Q1 		$120K Hold
14,030
– – ﹤0.01% 2453
2025
Q4 		$124K Sell
14,030
-592
-4% -$6.84K ﹤0.01% 2501
2025
Q3 		$194K Hold
14,622
– – ﹤0.01% 2335
2025
Q2 		$200K Hold
14,622
– – ﹤0.01% 2197
2025
Q1 		$201K Buy
14,622
+7,253
+98% +$106K ﹤0.01% 2199
2024
Q4 		$126K Hold
7,369
– – ﹤0.01% 2520
2024
Q3 		$135K Buy
+7,369
New +$130K ﹤0.01% 2489

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CastleKnight Management
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's ARDT Position: Q2 2026 in Review

MetLife Investment Management reduced its Ardent Health (ARDT) stake by 3% in Q2 2026, selling an estimated $4.03K and leaving 13,605 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

MetLife Investment Management first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $201K in Q1 2025. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • MetLife Investment Management held 13,605 shares of Ardent Health worth $134K as of Q2 2026.
  • MetLife Investment Management sold 425 Ardent Health shares in Q2 2026, an estimated $4.03K.
  • Ardent Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2635 holding.
  • MetLife Investment Management first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • MetLife Investment Management's Ardent Health position peaked at $201K in Q1 2025.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.